Trial Outcomes & Findings for Potency and Precision Investigation (NCT NCT06240091)

NCT ID: NCT06240091

Last Updated: 2025-02-19

Results Overview

Measure of working alliance. A 12-item measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy, and (c) development of an affective bond. For the purposes of the study, the word "therapist" was replaced with "Woebot". Total mean scores range from 1-5, with higher scores indicating greater alliance between the participant and Woebot.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

203 participants

Primary outcome timeframe

1 week and Post-treatment at 4 weeks

Results posted on

2025-02-19

Participant Flow

Participant milestones

Participant milestones
Measure
DISC-MA
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study. DISC-MA: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Overall Study
STARTED
203
Overall Study
COMPLETED
201
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Potency and Precision Investigation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
DISC-MA
n=203 Participants
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study. DISC-MA: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Race/Ethnicity, Customized
Non-Hispanic White
114 Participants
n=5 Participants
Region of Enrollment
United States
203 participants
n=5 Participants
Age, Continuous
43.22 years
STANDARD_DEVIATION 13.73 • n=5 Participants
Sex: Female, Male
Female
154 Participants
n=5 Participants
Sex: Female, Male
Male
49 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic or Latinx
21 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic American Indian or Alaskan Native
1 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic Asian
16 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic Black or African American
38 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic Middle Eastern or North African
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic more than one race
11 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 week and Post-treatment at 4 weeks

Population: Data missing

Measure of working alliance. A 12-item measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy, and (c) development of an affective bond. For the purposes of the study, the word "therapist" was replaced with "Woebot". Total mean scores range from 1-5, with higher scores indicating greater alliance between the participant and Woebot.

Outcome measures

Outcome measures
Measure
DISC-MA
n=201 Participants
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study. DISC-MA: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 1 Goal
3.63 score on a scale
Standard Deviation 0.98
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 1 Task
3.25 score on a scale
Standard Deviation 0.88
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 1 Bond
3.95 score on a scale
Standard Deviation 0.96
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 1 Total
3.61 score on a scale
Standard Deviation 0.83
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 4 Goal
3.72 score on a scale
Standard Deviation 0.99
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 4 Task
3.40 score on a scale
Standard Deviation 0.92
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 4 Bond
4.02 score on a scale
Standard Deviation 0.98
Working Alliance Inventory-Short Revised (WAI-SR), Total Scale
Week 4 Total
3.71 score on a scale
Standard Deviation 0.87

Adverse Events

DISC-MA

Serious events: 2 serious events
Other events: 56 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
DISC-MA
n=203 participants at risk
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study. DISC-MA: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Psychiatric disorders
Eating disorders and disturbances
0.49%
1/203 • Number of events 1 • 4 weeks
Psychiatric disorders
Active suicidal ideation
0.49%
1/203 • Number of events 1 • 4 weeks

Other adverse events

Other adverse events
Measure
DISC-MA
n=203 participants at risk
All participants will be asked to download and use the DISC-MA study application. They will have access to the app throughout the 4 week study. DISC-MA: DISC-MA is a digital program that utilizes elements from validated psychotherapies (e.g., cognitive behavioral therapy), with a relational agent (Woebot) that engages users in conversations with responses that are selected from a list based on natural language processing.
Psychiatric disorders
Psychiatric disorders
12.3%
25/203 • Number of events 37 • 4 weeks
General disorders
General disorders
2.0%
4/203 • Number of events 4 • 4 weeks
Surgical and medical procedures
Surgical and medical procedures
0.49%
1/203 • Number of events 1 • 4 weeks
Reproductive system and breast disorders
Prostatic disorder
0.99%
2/203 • Number of events 2 • 4 weeks
Nervous system disorders
Nervous system disorders
2.0%
4/203 • Number of events 4 • 4 weeks
Musculoskeletal and connective tissue disorders
Musculoskeletal and connective tissue disorders
3.0%
6/203 • Number of events 6 • 4 weeks
Gastrointestinal disorders
Gastrointestinal disorder
0.49%
1/203 • Number of events 1 • 4 weeks
Infections and infestations
Infections and infestations
1.5%
3/203 • Number of events 4 • 4 weeks
Investigations
Investigations
0.99%
2/203 • Number of events 2 • 4 weeks
Injury, poisoning and procedural complications
Injury, poisoning and procedural complications
0.99%
2/203 • Number of events 2 • 4 weeks
Eye disorders
Glaucoma
0.49%
1/203 • Number of events 1 • 4 weeks
Congenital, familial and genetic disorders
Chiari malformation
0.49%
1/203 • Number of events 1 • 4 weeks
Cardiac disorders
Chest pain
0.49%
1/203 • Number of events 1 • 4 weeks
Metabolism and nutrition disorders
Pre-diabetic
0.49%
1/203 • Number of events 1 • 4 weeks
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Parathyroid tumor
0.49%
1/203 • Number of events 1 • 4 weeks
Skin and subcutaneous tissue disorders
Surgical wound
0.49%
1/203 • Number of events 1 • 4 weeks

Additional Information

Tim Campellone, PhD

Woebot Health

Phone: (415) 209-5642

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place